Profession
Pittsburgh medical school, hospital set new policies for drug rep interactions
NEWS IN BRIEF — Posted Dec. 10, 2007
The University of Pittsburgh Schools of the Health Sciences and the University of Pittsburgh Medical Center are clamping down on pharmaceutical marketing with a new conflict-of-interest policy. As of Feb. 15, the two academic medical institutions will no longer allow:
Note: This item originally appeared at http://www.ama-assn.org/amednews/2007/12/10/prbf1210.htm.












